Cannabinoid receptor ligands

US7750158B2 · kind B2 · utility

Assignee

• SCHERING CORPORATION · US

Inventors

• Bandarpalle B. Shankar · Readington, US
• Eric J. Gilbert · Scotch Plains, US
• Razia Rizvi · Bloomfield, US
• Chunli Huang · Springfield, US
• Joseph A. Kozlowski · Princeton, US
• Stuart W. McCombie · Caldwell, US
• Neng-Yang Shih · Lexington, US

Key dates

• Filing date: Jun 21, 2005
• Grant date: Jul 6, 2010
• Expiry date: Nov 22, 2027

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/08
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of Formula I:and/or pharmaceutically acceptable salts, solvates or prodrugs thereof, or pharmaceutical compositions containing such compounds exhibit anti-inflammatory and immunomodulatory activity, and can be effective in treating cancer and inflammatory, immunomodulatory or respiratory diseases or conditions.